Abstract
| Original language | English |
|---|---|
| Pages (from-to) | S979-S985 |
| Journal | Journal of Thoracic Disease |
| Volume | 9 |
| Issue number | 2 |
| Publication status | Published - 2017 |
Fingerprint
Cite this
New generation bioresorbable scaffold technologies: An update on novel devices and clinical results. / Regazzoli, D; Leone, PP; Colombo, A; Latib, A.
In: Journal of Thoracic Disease, Vol. 9, No. 2, 2017, p. S979-S985.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - New generation bioresorbable scaffold technologies: An update on novel devices and clinical results
AU - Regazzoli, D
AU - Leone, PP
AU - Colombo, A
AU - Latib, A
PY - 2017
Y1 - 2017
N2 - Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology and may lead to some potential long-term advantages including the restoration of vasomotion, positive remodeling and a reduced incidence of late and very-late scaffold thrombosis (ScT). This technology, introduced to overcome limitations of current metallic drug-eluting stents (DES), is constantly and rapidly evolving with many companies working on bioresorbable devices. The aim of this review is to present an update on the most promising scaffolds that are under development. © Journal of Thoracic Disease.
AB - Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology and may lead to some potential long-term advantages including the restoration of vasomotion, positive remodeling and a reduced incidence of late and very-late scaffold thrombosis (ScT). This technology, introduced to overcome limitations of current metallic drug-eluting stents (DES), is constantly and rapidly evolving with many companies working on bioresorbable devices. The aim of this review is to present an update on the most promising scaffolds that are under development. © Journal of Thoracic Disease.
M3 - Article
VL - 9
SP - S979-S985
JO - Journal of Thoracic Disease
JF - Journal of Thoracic Disease
SN - 2072-1439
IS - 2
ER -